Top 50 Medical Angel Investors in United Kingdom (July 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Jonathan Milner
Angel
|
12 | United Kingdom, United States, Spain | Seed, Series A, Series B | Biotechnology, Health Care, Medical | $537k–$56M |
|
Ian Hogarth
Angel
|
3 | United Kingdom, United States, Germany | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, E-Commerce | $668k–$28M |
|
Mark Bamforth
Angel
|
2 | United Kingdom, United States | Series A, Seed | Health Care, Medical, Biotechnology | $2M–$19M |
|
Will Martin
Angel
|
2 | United Kingdom, Japan, United States | Seed, Series A | Software, Financial Services, FinTech | $655k–$11M |
|
Matt Clifford
Angel
|
2 | United Kingdom, United States, India | Seed, Pre-Seed | Software, FinTech, Artificial Intelligence | $55k–$7M |
|
Taavet Hinrikus
Angel
|
2 | United Kingdom, United States, Estonia | Seed, Series A, Series B | FinTech, Software, Financial Services | $1M–$50M |
|
Alexander Chesterman
Angel
|
2 | United Kingdom, France | Seed, Pre-Seed, Series A | FinTech, E-Commerce, Financial Services | $470k–$23M |
|
Matt Robinson
Angel
|
2 | United Kingdom, United States, Germany | Seed, Series A, Pre-Seed | Software, FinTech, Financial Services | $650k–$50M |
|
Will Brooks
Angel
|
2 | United Kingdom, United States | Seed, Series A | FinTech, Financial Services, Software | $524k–$30M |
|
Ariel Poler
Angel
|
2 | United States, Spain, Mexico | Seed, Series A, Angel | Software, Social Media, Internet | $455k–$7.9M |
|
Finn Russell
Angel
|
2 | United Kingdom | Angel, Venture - Series Unknown | Fitness, Medical, Wellness | |
|
Michael Pennington
Angel
|
2 | United Kingdom, United States, Spain | Seed, Pre-Seed | Software, SaaS, FinTech | $701k–$3M |
|
Evelyn Bourke
Angel
|
1 | United Kingdom | Pre-Seed, Seed, Series B | InsurTech, Insurance, Software | $360k–$26M |
|
Ron Zuckerman
Angel
|
1 | Israel, United States, China | Series A, Seed | Internet, Video, Apps | $500k–$8M |
|
Adam Niewinski
Angel
|
1 | Poland, Singapore, United States | Series A, Seed | FinTech, Financial Services, AgTech | $2M–$68M |
|
Manny Kadre
Angel
|
1 | United Kingdom | Seed | Medical, Health Care, Medical Device | |
|
Mart Abramov
Angel
|
1 | United Kingdom | Pre-Seed | Legal, Legal Tech, Marketplace | |
|
Patrick Bamford
Angel
|
1 | United Kingdom | Series A | B2C, Shoes, Sporting Goods | |
|
Jon Moulton
Angel
|
1 | United Kingdom, Cyprus, Luxembourg | Seed, Series A | Financial Services, FinTech, Banking | |
|
Mark Cuban
Angel
|
1 | United States, Vietnam, Singapore | Seed, Series A, Angel | Blockchain, Software, E-Commerce | |
|
Duncan Grierson
Angel
|
1 | United Kingdom | Seed, Series A | Water, Medical, CleanTech | |
|
Paul Roy
Angel
|
1 | United Kingdom | Seed | Fitness, Medical, Wellness | |
|
Richard Reed
Angel
|
1 | United Kingdom, United States | Seed, Series A | Content, Food and Beverage, Pharmaceutical | |
|
Jonathan Lenson
Angel
|
1 | United Kingdom, Israel | Seed, Grant, Pre-Seed | Software, Information Technology, Internet | |
|
Bob Davis
Angel
|
1 | United States, United Kingdom | Series A, Series B, Series C | Internet, Advertising, Social Network | |
|
Thomas Dyrberg
Angel
|
1 | United States, United Kingdom, Switzerland | Series B, Series C, Seed | Biotechnology, Medical, Health Care | |
|
Flavien Kulawik
Angel
|
1 | France, United Kingdom | Seed, Series A | Health Care, Artificial Intelligence, SaaS | |
|
Pa Nolan
Angel
|
1 | Ireland, United Kingdom | Seed | Medical, Delivery, Shipping | |
|
Arthur Chen
Angel
|
1 | United Kingdom | Seed, Series A | Medical, Chemical, Software | |
|
Emilio Püschmann
Angel
|
1 | United Kingdom | Pre-Seed | Medical, Database, Consulting | |
|
Nicolaus Henke
Angel
|
1 | United Kingdom | Seed, Pre-Seed | Information Technology, SaaS, Medical | |
|
John Taysom
Angel
|
1 | United Kingdom, United States | Seed, Angel, Series A | Software, Information Technology, Artificial Intelligence | |
|
Peer Schatz
Angel
|
1 | United States, United Kingdom | Seed | Medical, Genetics, Health Care | |
|
Will Armitage
Angel
|
1 | United Kingdom, Chile | Seed, Angel, Pre-Seed | FinTech, Software, Health Care | |
|
Sidar Sahin
Angel
|
1 | United Kingdom | Series A | Medical, mHealth, Health Care | |
|
Andrew MacKay
Angel
|
1 | United Kingdom | Seed | Medical, Hospital, Health Care | |
|
Henry Carleton
Angel
|
1 | United Kingdom | Series A | Medical, Health Care, Health Diagnostics | |
|
Sachin Agrawal
Angel
|
1 | United Kingdom | Series A | Medical, Health Care, Health Diagnostics | |
|
David Prior
Angel
|
1 | Belgium, United Kingdom | Seed | Health Care, Medical, Software | |
|
Johnathan Matlock
Angel
|
1 | United Kingdom | Seed, Pre-Seed | Biotechnology, Medical, Health Care | |
|
Jim Mellon
Angel
|
1 | United States, United Kingdom, Israel | Series A, Seed | Biotechnology, Health Care, Food and Beverage | |
|
Brian Kennedy
Angel
|
1 | United States, United Kingdom | Angel | Music, Medical, Commercial | |
|
Carlos Ballarati
Angel
|
1 | United Kingdom | Pre-Seed | Medical, Database, Consulting | |
|
Yusuf Hamied
Angel
|
1 | United Kingdom | Seed | Medical, Medical Device | |
|
Brian Souter
Angel
|
1 | United Kingdom | Medical, Commercial, Health Care | ||
|
Anand Mahindra
Angel
|
1 | India, United States, United Kingdom | Seed, Angel, Series A | Education, Artificial Intelligence, Social Media | |
|
Inaki Berenguer
Angel
|
1 | Spain, United States, United Kingdom | Seed, Angel, Pre-Seed | Financial Services, FinTech, E-Commerce | |
|
Alex Macdonald
Angel
|
1 | United Kingdom, United States, France | Pre-Seed, Seed, Series A | Software, Artificial Intelligence, FinTech | |
|
Charlotte Scott
Angel
|
1 | United Kingdom | Seed | Medical, Health Care, Pharmaceutical | |
|
Phil Kirby
Angel
|
1 | United Kingdom | Seed | Medical, Hospital, Medical Device | |
| Access all 141 angel investors in United Kingdom Medical startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Spain
Investor stats
- Total investments: 61
- Round size: Seed $537k–$25M; Series A $4.1M–$50M; Series B $1.6M–$56M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Quibim — Quibim builds AI tools that turn MRI, CT and PET data into actionable predictions for hospitals and biopharma. Trusted in 230+ centers worldwide.
- Nuclera — Nuclera makes biology accessible through desktop enzymatic protein and gene synthesis. Nuclera has since grown to fifty-seven employees across two continents as the Company delivers on its founders’ vision to make biology accessible to everyone through desktop bioprinting. With desktop bioprinting, researchers and scientists will be empowered totake control of biology through streamlined access to a next-day supply of proteins and genes.
- 52 North Health — At 52 North we are developing fully-integrated clinical, AI and medical-device based systems.
Ian Hogarth is based out of London, England, and is the Chairman of Phasecraft. Ian previously worked at Songkick as a Chairman. Ian Hogarth attended the University of Cambridge.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, E-Commerce
- Stage:Seed, Series A, Pre-Seed
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 56
- Round size: Seed $1.5M–$7.9M; Pre-Seed $668k–$7.5M; Series A $11M–$28M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Unitary — We detect harmful content with context-aware AI to keep brands and platforms safe online.
- Cordless — Bridging the gap between voice and text
- Fabric — Fabric is an AI-powered workspace and file manager for people and groups.Fabric is a self-organizing multiplayer workspace.
Mark Robert Bamforth is based out of Boston, Massachusetts and is the Chief Executive Officer of disAMR and Executive Advisor of Ampersand Capital Partners. Mark previously worked at Kincell Bio as a Chief Executive Officer. Mark Robert Bamforth attended the Henley Business School.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Seed
- Geography: United Kingdom, United States
Investor stats
- Total investments: 15
- Round size: Seed $2M–$7M; Series A $9.2M–$19M
- Lead/follow: 47% lead, 53% follow
Portfolio highlights
- Talking Medicines — Data Science for Life Sciences. Talking Medicines turns unstructured health data into actionable intelligence that proves real marketing impact.
- Thymmune Therapeutics — Thymmune Therapeutics is developing a machine learning-driven thymic cell engineering platform to restore normal immune function in aging and disease.
- CONTINUUS Pharmaceuticals — CONTINUUS Pharmaceuticals works with pharmaceutical and generic companies under a Build-Own-Operate model. They design, build, and run the manufacturing process directly at the client site. This novel business model provides its clients with an exceptional, ”one-shop solution” for their entire development and manufacturing cycle. CONTINUUSPharmaceuticals is leveraging a novel continuous manufacturing platform called Integrated Continuous Manufacturing (ICM), initially developed through an $85 M joint research project between Novartis and MIT. In addition, the company is currently collaborating with hospital systems and pharmacy chains to establish its own generic business, where high-quality, low-cost drugs will be manufactured in the United States.
Will Martin - Founder and Director @ Portfolio Ventures
Show more...Investment focus
- Industry: Software, Financial Services, FinTech
- Stage:Seed, Series A
- Geography: United Kingdom, Japan, United States
Investor stats
- Total investments: 88
- Round size: Seed $655k–$5.5M; Series A $2.2M–$11M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Bequest — Digital estate planning made easy for professionals and individuals. Securely protect online accounts, cryptocurrencies, emails, media, documents and more.
- Disputed — FinLegal is legaltech for the business of disputes. Our solutions allow you to fund and insure your litigation through litigation funding and after-the-event insurance, automate volume and class actions and get more clients through working with marketing service providers.
- Robin — Robin AI is a legal tech company based in London, made up of engineers, lawyers, scientists and operations specialists.
Matt co-founded EF after being a consultant at McKinsey & Co. Prior to EF Matt spent his time studying at MIT fuelled by an obsession with R, Python and unusual datasets. EF is the best place for Europe’s top technical individuals to meet and build world-changing startups in London.They select purely on the basis of technical talent, so youcan apply before you have a team or an idea. The intensive 6-month programme is designed to give you the best possible support in the first 200 days of your startup’s life.They have created over 40 startups now worth over $300 million. The startups are funded by some prestigious investors including Balderton Capital, Index Ventures, Octopus Investments and Y Combinator.
Show more...Investment focus
- Industry: Software, FinTech, Artificial Intelligence
- Stage:Seed, Pre-Seed
- Geography: United Kingdom, United States, India
Investor stats
- Total investments: 40
- Round size: Seed $764k–$7M; Pre-Seed $55k–$4.2M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Stackfix — Stackfix operates as a software comparison platform.
- Rivan Industries — Rivan Industries designs and builds modular, vertically integrated, synthetic fuel plants.
- Asymmetric Security — Asymmetric Security is an AI-native cybersecurity startup specializing in digital forensics and incident response. It combines elite forensic experts with proprietary AI to accelerate investigations, especially Business Email Compromise (BEC) attacks, at less than half the cost of competitors while shrinking timelines from days to hours.
Taavet Hinrikus is based out of London, England and is the Partner of Plural Platform and Board Member of CoMind. Taavet previously worked at Wise as a Chairman and Co-founder. Taavet Hinrikus attended INSEAD.
Show more...Investment focus
- Industry: FinTech, Software, Financial Services
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Estonia
Investor stats
- Total investments: 127
- Round size: Seed $1M–$7.9M; Series A $7M–$47M; Series B $23M–$50M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Feather — Feather gives you insurance advice for expats in Germany. Our digital insurance agent will help you get the right insurance policies for your need.
- Habito — We're the Treating Customers Fairly Champion of 2023 as voted for in the British Bank Awards. We're here to make mortgages easier - no paperwork, no stress and no fees.
- Entrepreneurs First — We turn exceptional individuals into funded founders. We back you first, then give you a bridge to Silicon Valley.
Alex Chesterman is the Co-Founder of Houseful. Alex Chesterman attended the University College London.
Show more...Investment focus
- Industry: FinTech, E-Commerce, Financial Services
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, France
Investor stats
- Total investments: 42
- Round size: Seed $524k–$4.8M; Pre-Seed $470k–$3M; Series A $2.3M–$23M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- Atheni AI — Atheni focused on embedding AI guidance directly into day-to-day workflows rather than relying on standalone training sessions or workshops.
- Zefir — Zefir aims to expand the realm of possibilities for millions of European homeowners. We make home-selling simpler, faster and more certain by buying the property directly from you. Selling a home is now just a few clicks away.
- Pharmacierge — Pharmacierge is the digital e-prescribing service chosen by private clinicians to deliver medication to their patients throughout the UK and worldwide. Clinicians create and transfer e-prescriptions to our pharmacy near London's Harley Street, for free delivery to their patients either the same day or next weekday
Matt Robinson is the CEO and a co-founder at Nested, a property technology company. Prior to this, he founded GoCardless in 2010 and remains on the board of the recurring payment company.
Show more...Investment focus
- Industry: Software, FinTech, Financial Services
- Stage:Seed, Series A, Pre-Seed
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 73
- Round size: Seed $1.8M–$7.9M; Pre-Seed $650k–$3M; Series A $6.4M–$50M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Malga — Malga is an online payment platform that offers fraud protection and payment split services.
- Feather — Feather gives you insurance advice for expats in Germany. Our digital insurance agent will help you get the right insurance policies for your need.
- Malga — Instant access to multiple payment providers with a single integration
Will Brooks - Founder & Director @ Portfolio Ventures
Show more...Investment focus
- Industry: FinTech, Financial Services, Software
- Stage:Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 69
- Round size: Seed $524k–$3.1M; Series A $2.2M–$30M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Bequest — Digital estate planning made easy for professionals and individuals. Securely protect online accounts, cryptocurrencies, emails, media, documents and more.
- Disputed — FinLegal is legaltech for the business of disputes. Our solutions allow you to fund and insure your litigation through litigation funding and after-the-event insurance, automate volume and class actions and get more clients through working with marketing service providers.
- Robin — Robin AI is a legal tech company based in London, made up of engineers, lawyers, scientists and operations specialists.
Ariel Poler is the Co-Founder of Reveri Health. Ariel is an Internet entrepreneur, mentor, and investor. He was the founder of IPRO, the first web analytics company, and of Topica, one of the first email communities. Ariel was a board member of Kana Software, LinkExchange, Odeo, LOLapps, and StumbleUpon. He currently serves on the boards of FreedomFinancial Network, MixTent, Strava, and Scan Inc. Ariel’s angel investments include AdMob, Flixster, Slideshare, Xobni, RockYou, and Outright, BrightRoll, Instructables, Causes, Kongregate and NexTag. Ariel holds a B.S. in Mathematics with Computer Science from MIT and an MBA from Stanford University. He is originally from Venezuela and lives in San Francisco with his wife and three children.
Show more...Investment focus
- Industry: Software, Social Media, Internet
- Stage:Seed, Series A, Angel
- Geography: United States, Spain, Mexico
Investor stats
- Total investments: 45
- Round size: Seed $455k–$7M; Angel $1M–$1.7M; Series A $3M–$7.9M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Goin — Goin is a mobile application to save money easily and take advantage of it without knowing how to invest, through Machine Learning algorithms that allow you to accumulate the user's money through small daily gestures. he three Spanish founders, David, Carlos and Gabriel, were looking for a way to optimize their own money, and decided toconduct an experiment by exchanging their debit cards and thus saving 62% during those two months of rehearsal. This is how Goin emerged, which aims to meet the needs of 100% of Millennials, of which 83% confess that they do not know how to save, making available an easy-to-use tool that enhances their finances and lifestyle. On the one hand, the Barcelona startup allows the user to add money automatically and multiply it without having previous knowledge of investment. Goin uses a simple system that first asks to know the user through questions about their habits and, in this way, they are offered automatic systems and methods of saving. Once the user adds money to the app, they can transfer part or all of it to investment, or to their bank account. Its Smart Saving technology manages to accumulate money with small, everyday gestures, such as rounding a payment.
- Kiwibot — Delivery robots to optimize your business and deliver safely and timely to your customers.
- Grin Scooters — Grin Scooters is a software company that operates network of operational shared electric scooters. Currently, Grin only operates in Mexico City, Guadalajara, Monterrey, Sao Paulo and Bogota but it has plans to expand to other cities throughout Latin America.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Finn Russell is a Scottish rugby union player.
Show more...Investment focus
- Industry: Fitness, Medical, Wellness
- Stage:Angel, Venture - Series Unknown
- Geography: United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Puresport — Puresport was created to craft the finest, premium-quality natural products to support every element of wellbeing, from pain & recovery, to sleep, focus, mood, stress, and balance.
One of the UK's leading tech angel investors. Active seed and pre-seed stage angel investor in UK based disruptive tech. Prefers businesses venturing into pastures new and keen investing at the pre product stage whether BtoC or B2B. Twice exited UK based tech entrepreneur with experience operating tech businesses in 20 countries in multiplelanguages. Co-founded Gumtree with Simon Crookall which was acquired by Ebay and Slando acquired by Naspers.
Show more...Investment focus
- Industry: Software, SaaS, FinTech
- Stage:Seed, Pre-Seed
- Geography: United Kingdom, United States, Spain
Investor stats
- Total investments: 34
- Round size: Seed $750k–$3M; Pre-Seed $701k–$2.1M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- Hubflo — Hubflo is building an all-in-one work OS to help small businesses manage their business. Instead of having 10 complicated and expensive pieces of software, Hubflo offers SMB everything they need to run their business (CRM, projects, invoicing, expenses...) in a single comprehensive, simple and affordable platform.
- FUEL — Where everlasting fanbases are built
- Sidekick — Expertly-managed portfolios for the modern investor
Evelyn was appointed Bupa’s Group CEO in July 2016, having been Acting Group CEO from April 2016. She is also a member of the Bupa Board and Nomination & Governance Committee.She has a strong track record in global executive management and extensive experience in financial services, risk and capital management, and mergers and acquisitions.Evelyn joined Bupa as CFO in September 2012, from Friends Life where she was Chief Executive Officer of its Heritage division. Previously at Friends Provident, she was the Executive Director responsible for strategy, capital and risk and, before that, Chief Financial Officer.Evelyn grew up on a dairy farm in Ireland and she’s the eldest of six. She was one of the first two women in Ireland to qualify as actuaries. She began her career with New Ireland Assurance and Bank of Ireland. She holds an MBA from London Business School and was previously a Non-Executive Director of the IFG Group in Ireland. Evelyn is currently a Non-Executive Director of the Bank of Ireland Group plc and a member of their Audit Committee and Nomination and Governance Committee.On becoming Group CEO in April 2016, Evelyn established a clear Strategic Framework to focus the organisation on delivering for customers.Evelyn believes strongly in promoting diversity in the workplace and empowering people to deliver high standards of service and care for customers.
Show more...Investment focus
- Industry: InsurTech, Insurance, Software
- Stage:Pre-Seed, Seed, Series B
- Geography: United Kingdom
Investor stats
- Total investments: 12
- Round size: Seed $1.9M–$7.9M; Pre-Seed $360k–$1.3M; Series B $25M–$26M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Hybr — Find your next student accommodation with Hybr, the UK's best student letting platform. Over 5000 happy students served. Click to find your next property.
- Klarytee — Klarytee is a SaaS platform that builds security into sensitive content to enable granular control wherever the data goes
- The Electric Car Scheme — Salary sacrifice lets employees pay for an electric car from their gross salary before tax. It's basically the Cycle to Work scheme but for electric cars.
Ron Zuckerman is based out of Berlin, Berlin, and is the Advisory Council of Börse Stuttgart group. Ron previously worked at Attunity as a Board Member.
Show more...Investment focus
- Industry: Internet, Video, Apps
- Stage:Series A, Seed
- Geography: Israel, United States, China
Investor stats
- Total investments: 18
- Round size: Seed $500k–$8M; Series A $1M–$8M
- Lead/follow: 22% lead, 78% follow
Portfolio highlights
- Craft.io — Plan & manage your products with craft.io. A comprehensive, streamlined, intuitive product management platform built for product managers.
- MedHub-AI — MedHub-AI develops deep-learning video analysis algorithms that provide accurate diagnostic insights and practical guidance for physicians. Users can incorporate its algorithm into medical video systems to improve the decision-making process for cardiologists and other physicians. Its technology uses multiple technological and big-data processingmethods designed to handle a massive amount of clinical data, both visual and textual. It designs its algorithms to improve physicians' performance and shorten procedure times by providing a multilayered automated system that is implemented from diagnosis to practical procedural guidance and documentation. It currently offers solutions for the cardiology and gastroenterology markets.
- Safeguard Applied Innovation — Safeguard Applied Innovation provides a mobile performance management platform for construction enterprises. It designs its solution to enable decision-making for successful project planning and execution, delivering effective control regardless of project complexity or national regulations.
Adam Niewinski is based out of Warsaw, Mazowieckie, and is the Co-Founder & General Partner of OTB Ventures. Adam previously worked at Xelion Investment House as the Chairman of the Supervisory Board. Adam Niewinski attended the SGH Warsaw School of Economics.
Show more...Investment focus
- Industry: FinTech, Financial Services, AgTech
- Stage:Series A, Seed
- Geography: Poland, Singapore, United States
Investor stats
- Total investments: 21
- Round size: Seed $2M–$10M; Series A $6.2M–$68M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- ITaxi — ITaxi is a free mobile application, allowing its users to order cabs through its application. Its users do not have to know Polish to use the application as they can decide by type and model of the car, rate per kilometer, and time.ITaxi cooperates with local taxi federations and it has fleet of 10, 000 vehicles in over 100 cities all over thecountry, including Warsaw, Cracow, Lodz, Wroclaw, Gdansk, and Poznan. Launched in 2012 the application is based in Poland.
- OrganOx — OrganOx Limited was founded in 2008 to exploit normothermic preservation technology invented by Prof Peter Friend and colleagues and further developed by Prof Constantin Coussios at the University of Oxford.
- Audioteka — Audioteka is a mobile and multi-language audiobook application for smartphones/tablets with a dedicated audiobook car platform. They offer audiobooks in 9 languages in 23 countries.They strive to bring stories back into the lives of busy people through the creative use of technologies. They want everyone to try an audiobook at least once.They're confident you'll enjoy this new medium. People really can be smarter and better entertained thanks to their stories.They edit and produce audiobooks, collaborate with actors, inspire new and innovative productions and in doing so they offer unique content that can’t be found in any other audiobook store. Audioteka strives to give its customers the highest quality content via ready-to-use mobile solutions. They understand their mobile users and continue to learn from them every day. That is why they've created the world's most seamless platform for enjoying valuable spoken word content while on the go!
Manny Kadre
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Stage:Seed
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- TympaHealth — The award-winning Tympa system is designed to empower clinicians to deliver ear and hearing healthcare within local communities.
Mart Abramov - Co-founder/ CEO @ TaxScouts
Show more...Investment focus
- Industry: Legal, Legal Tech, Marketplace
- Stage:Pre-Seed
- Geography: United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Legal Nodes — Offload your legal tasks to a virtual legal department and get on with running your business. Get started with the Legal Nodes platform for free.
- Emerald — Take control of your long-term health with Emerald. Get continuous GP support, in-depth screenings, wearable data integration, and a personalised plan to prevent disease and boost longevity.
Patrick Bamford
Show more...Investment focus
- Industry: B2C, Shoes, Sporting Goods
- Stage:Series A
- Geography: United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Emerald — Take control of your long-term health with Emerald. Get continuous GP support, in-depth screenings, wearable data integration, and a personalised plan to prevent disease and boost longevity.
- Hylo Athletics — Hylo Athletics manufactures Athletic Footwear.
Jon Moulton is a British venture capitalist. He is the founder and managing partner of the private equity firm Better Capital, and is the former managing partner of the private equity firm Alchemy Partners.
Show more...Investment focus
- Industry: Financial Services, FinTech, Banking
- Stage:Seed, Series A
- Geography: United Kingdom, Cyprus, Luxembourg
Investor stats
- Total investments: 18
- Lead/follow: no public data
Portfolio highlights
- Pockit — Open a prepaid account in 3 minutes online or in-app, get your contactless prepaid card in 2 working days with no credit check.
- Hometree — Keep yourself warm with Hometree, and try our no price hike promise. Compare our different boiler & home cover plans to see how you can save.
- Hellas Direct — Hellas Direct is a digital-first, full-stack insurance company, empowered by cutting-edge technology and artificial intelligence. The Cyprus-based company is backed by a roster of leading investors, including Portag3, IFC (a member of the World Bank), Endeavor Catalyst, former Goldman Sachs economist Lord O’Neill and private equity veteran JonMoulton. Modelling itself on Amazon, Hellas Direct aims to disrupt the insurance value chain by adopting an extreme focus on operational excellence.
Mark Cuban is the founder of Fireside, Chairman and Founding Partner of AXS TV, and the Owner of Dallas Mavericks. He previously worked at Broadcast.com as a Co-Founder. Mark Cuban attended the Indiana University Bloomington.
Show more...Investment focus
- Industry: Blockchain, Software, E-Commerce
- Stage:Seed, Series A, Angel
- Geography: United States, Vietnam, Singapore
Investor stats
- Total investments: 126
- Lead/follow: no public data
Portfolio highlights
- ESAI — Join over 500,000 students crafting their story
- Kind Designs — We specialize in Seawall Construction using advanced 3D-printing technology in Florida. Get a free consultation today!
- Campus Ink - NIL Store — Campus Ink Screen Printing & Embroidery, Champaign - Urbana, Custom T-Shirts, Fraternity & Sorority Apparel Simple
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Duncan Grierson
Show more...Investment focus
- Industry: Water, Medical, CleanTech
- Stage:Seed, Series A
- Geography: United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Puraffinity — Puraffinity develops targeted materials for water treatment, focused on forever chemicals called PFAS. Our strategic intent is to provide 1 billion people with PFAS safe water by 2030
- Moixa Technology — Moixa Technology develops the Maslow intelligent energy storage solution, enabling homes to store energy and benefit from revenue streams generated by trading energy through GridShare, an SaaS platform that aggregates energy from groups of Maslow energy storage systems. . The company develops smart DC technologies to power DC lighting, computing,electronics from grid-shifted storage or local PV from smart DC hubs, variable DC networks and sockets. The technology and IPR reduces grid peak by shifting DC device load and powering DC devices efficiently without inverters or AC/DC adaptors, together with providing smart control and energy management. The technology aims to address the 1 trillion kwh + lost annually in power conversion, and the significant growing DC demand in homes, offices from ICT, LED lighting and the rise in internet connected devices.
He was a founding partner and chairman of NewSmith Asset management, a fund manager for a wide range of institutional, pension fund and high net worth investors. Having started his career at the stockbroking firm Kemp Gee he subsequently became senior partner following the merger with Scrimgeour Vickers and Citibank. In 1988 he joined Smith Newcourt, the leading market making firm on the London Stock Exchange and as CEO, together with chairman Michael Marks merged the business with Merrill Lynch in 1995. At Merrill, Paul held a number of senior positions including head of Global Equities and in 2001 was made EVP and president of Merrill Lynch Global Markets and investment banking, responsible for the firm’s investment banking, debt and equity business worldwide. He left Merrill in 2003 to start NewSmith.He has served as a non executive director of Benfield plc and Cenkos securities and is currently Chairman of New River Retail plc the leading UK REIT specialising in retail property investment.Between 2007 and 2013 Paul served two terms as Chairman of the newly created British Horse Racing Authority, responsible for the Governance and Regulation of the country’s second largest sport. He is now Chairman of ROR, the sports main charity, responsible for ensuring that horses are cared for, retrained, and re-homed, after their racing careers are over. He has a Bachelor of Arts (Honours) degree in Economics from Liverpool University and in 2009 was awarded an Honoury Doctorate of Law from Liverpool University.
Show more...Investment focus
- Industry: Fitness, Medical, Wellness
- Stage:Seed
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Qured — Get affordable and reliable PCR Fit to Fly tests and Antigen Fit to Fly tests from Qured. Fast results. Recommended by global airlines, UKAS accredited.
Richard is the founder of Innocent Drinks, UK's number 1 smoothie brand. In 2009 The Coca-Cola Company acquired a minority stake in Innocent Drinks and in 2013 the stake was increased to over 90%. Innocent Drinks gives 10% of its profits to charity. Richard is known to have implemented a google-like working atmosphere at InnocentDrinks' offices, where people feel like at home. He appeared in sereval high profile TV shows and documentaries, here is a documentary with Peter Jones from Drangon's Den (UK's equivalent of Shark Tank) He is now a successful investor through his company JamJar Investments, where they invest in strong teams with an idea that consumers love.
Show more...Investment focus
- Industry: Content, Food and Beverage, Pharmaceutical
- Stage:Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 14
- Lead/follow: no public data
Portfolio highlights
- Simba Sleep — One Mattress. Five Layers of Comfort. Tailored to Suit All. Bringing together experience & technology so that your mattress gives you the best night's sleep.
- Beckley Psytech — Our mission is to help people suffering from neurological and psychiatric conditions by developing our pipeline of psychedelic compounds.
- Beckley Canopy Therapeutics — Beckley Canopy Therapeutics is a biopharmaceutical company designed to research cannabis health products.
Jonathan Lenson
Show more...Investment focus
- Industry: Software, Information Technology, Internet
- Stage:Seed, Grant, Pre-Seed
- Geography: United Kingdom, Israel
Investor stats
- Total investments: 13
- Lead/follow: no public data
Portfolio highlights
- Fertifa — Fertifa is an innovative employer benefit solution making fertility care more accessible and affordable.The company works with employers to offer a valuable employee benefit which bridges the gap between an employer and their employees when dealing with the sensitivity and privacy of employees’ reproductive issues. It also offers guidance andadvice, next-generation fertility treatment, and access to a range of holistic services for the best chance of success. The company was founded in 2019 and based in London, United Kingdom.
- Roleshare — Roleshare matches freelancers, part-time and fractional workers to job share; helping companies retain and attract coveted skills and talent. Join us!
- Surfboard — Get Dialpad Workforce Management (WFM) software for accurate forecasting, demand-driven scheduling, fair shift planning, and more.
Bob Davis is a General Partner at Highland Capital Partners and an Executive Chairman at Highland Transcend Partners. He was a CEO at Lycos. Bob attended Northeastern University and Babson College.
Show more...Investment focus
- Industry: Internet, Advertising, Social Network
- Stage:Series A, Series B, Series C
- Geography: United States, United Kingdom
Investor stats
- Total investments: 14
- Lead/follow: no public data
Portfolio highlights
- LovePop — Buy online, personalize, schedule and send 3D pop-up cards with free shipping. Lovepop has greeting cards & paper art for every occasion. A Lovepop is a beautiful keepsake that unfolds like a miniature surprise.
- TympaHealth — The award-winning Tympa system is designed to empower clinicians to deliver ear and hearing healthcare within local communities.
- Vecna Robotics — Vecna Robotics is the leading autonomous mobile robot (AMR) company that provides logistics automation and workflow optimization solutions.
Thomas P. Dyrberg, M.D., Ph.D., serves as Senior Partner of Novo Ventures and Novo A/S. Thomas Dyrberg joined Novo A/S in December 2000, where he was a Partner.He held research positions at the Hagedorn Research Institute, Gentofte, Denmark and at the Scripps Research Institute, La Jolla, California.In 1990, he joined Novo NordiskA/S and worked in health care discovery on various aspects of diabetes immunology and pathogenesis and health Care Clinical Drug Development as an International Clinical Project Manager since 1996. He serves as the Deputy Chairman of Veloxis Pharmaceuticals A/S and has been its Director since September 2003.Thomas Dyrberg has been a Director at Gloucester Pharmaceuticals, Inc. since August 25, 2009. He serves as a Director at Rejuvenon, Corp, Allocure Inc., Veloxis, Lux Biosciences, Inc., Ophthotech Corporation, Sapphire Therapeutics Inc., and Delenex Therapeutics AG.He served as a Director of BioMimetic Therapeutics, Inc. from May 2001 to June 21, 2007. He served as a Director of Helsinn Therapeutics (U.S.), Inc. He has published several articles within the fields of diabetes, immunology, and autoimmunity.Thomas Dyrberg has an M.D. degree in 1981 and his DM.Sc. degree from the University of Copenhagen in 1986.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Series B, Series C, Seed
- Geography: United States, United Kingdom, Switzerland
Investor stats
- Total investments: 16
- Lead/follow: no public data
Portfolio highlights
- PanOptica — PanOptica is a biopharmaceutical company developing a topical eye drop for the treatment of eye diseases caused by abnormal or leaky blood vessels.
- Pangaea Data — Find & connect with more patients, at scale, for therapies, clinical trials and drug discovery studies.
- Freeline — A leading biotechnology company focused on innovative liver directed gene therapies for bleeding disorders and other debilitating, chronic diseases
Flavien Kulawik
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, SaaS
- Stage:Seed, Series A
- Geography: France, United Kingdom
Investor stats
- Total investments: 11
- Lead/follow: no public data
Portfolio highlights
- Adionics — Adionics provides advances ionic solutions such as lithium and iodide extraction, and salts separation.
- Biomemory — Biomemory creates DNA Drives for large corporates and administrations.
- Scienta Lab — Redefining precision immunology
Pa Nolan
Show more...Investment focus
- Industry: Medical, Delivery, Shipping
- Stage:Seed
- Geography: Ireland, United Kingdom
Investor stats
- Total investments: 6
- Lead/follow: no public data
Portfolio highlights
- SiSaf — SiSaf delivers on the promise of RNA therapeutics with Bio-Courier technology.
- Scurri — Scurri is next generation delivery management software that puts retailers back in control. Explore our delivery management software today.
Arthur Chen is a Managing Partner at Ameba Capital.
Show more...Investment focus
- Industry: Medical, Chemical, Software
- Stage:Seed, Series A
- Geography: United Kingdom
Investor stats
- Total investments: 4
- Lead/follow: no public data
Portfolio highlights
- Porotech — All-in-One MicroLEDs for Everyone, Everywhere, Every Device Unleashing the Power of Light Our MicroLED technology revolutionises the way displays are manufactured, making microLED displays possible for everyone. Through our partnerships and dedicated R&D teams we develop new technologies and can succeed together with you. compare to the conventional LED Porotech is here for your every
- Pangaea Data — Find & connect with more patients, at scale, for therapies, clinical trials and drug discovery studies.
Emilio Püschmann
Show more...Investment focus
- Industry: Medical, Database, Consulting
- Stage:Pre-Seed
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- OPEN Health — OPEN Health is a healthcare agency that provides market access strategy, health economic modeling and meta-analysis patient engagement, patient-centered outcomes, real-world evidence and data analytics, medical affairs consultancy and strategy, publications planning and delivery, scientific, communications, learning and development.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Nicolaus Henke is a senior partner at McKinsey & Company, where he advises leading companies on how to improve decision making and performance through advanced analytics, artificial intelligence, and end-to-end data enabled transformations, and is the global leader of McKinsey Analytics, which has more than 2,000 dedicated analyticspractitioners and translators, where he oversees partnerships between McKinsey and the wider artificial intelligence, data, and computing ecosystem. Nicolaus is the chairman of QuantumBlack (acquired by McKinsey in 2015), a company operating at the intersection of strategy, technology, and design, and a member of McKinsey’s global board, the Shareholder’s Council. He helped found and is a member of the Board of Innovative Healthcare Delivery at Duke Medicine and serves on the Dean’s Advisory Council at Harvard’s Kennedy School. Nicolaus frequently speaks on big data, analytics, and healthcare topics at global forums such as the World Economic Forum, the Milken Institute, and Forbes. He holds a master’s degree and PhD in business from the University of Münster, Germany, and a master’s in public administration from Harvard University, where he was a John J. McCloy Scholar.
Show more...Investment focus
- Industry: Information Technology, SaaS, Medical
- Stage:Seed, Pre-Seed
- Geography: United Kingdom
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- seedata.io — Honeypots, but better! Seedata.io provides cloud-native deception technology to improve threat detection with AI-driven honeypots.
- Little Journey — Little Journey supports children and their families before, during and after healthcare interactions, reducing anxiety and improving health outcomes
- Oxford Medical Simulation — Drive clinical competency with OMS. Combining healthcare education and competency assessment with dynamic virtual reality simulations.
John Taysom started the Reuters Venture Capital Fund in Palo Alto in 1995 making 82 investments in internet and web infrastructure and services including Verisign, UltraDNS, Digimarc, ZeroKnowledge and Intertrust. He was a member of the Board of Digimarc pre and post its Nasdaq IPO, a Board member at Intertrust and a Board member at TIBCO throughits Nasdaq IPO. To date, seventeen of his investments have achieved an IPO.John acquired the Fund in an MBO in 2002. Now London-based with a seed portfolio of thirty US and UK start-ups; one has achieved an IPO and several have been acquired by Experian, Linkedin, Tesco, BMC and others.In 2011 and 2012 John took a Fellowship at Harvard to work on privacy issues and holds EU and US patents on a method of improving privacy online. For 2015 John is a Policy Fellow at the University of Cambridge Centre for Science and Policy and a Visiting Professor, Department of Computer Science, at UCL. He is a member of the Board of the Web Science Trust; chairs Performance Horizon, a fast growing UK startup; is a Governor at Hurstpierpoint College; and runs a small farm in Devon.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Angel, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 16
- Lead/follow: no public data
Portfolio highlights
- LGN — LGN's edge AI management software puts you in complete technical and financial control of your edge AI systems.
- Tenyks — Tenyks gives Computer Vision Engineers the insights to build more reliable models faster! Collaborate to identify and fix dataset issues. Improve data quality. Boost model performance. No more wondering in the dark.
- Worldr — Valarian | Innovating for the new era of digital sovereignty
1989, Master's in Finance, Univ. of St Gallen, Switzerland; 1991, MBA in Finance, Graduate School of Business, Univ. of Chicago. Former: Partner, private management buy-out group, Switzerland; finance and systems positions, Sandoz and Computerland; finance, operations, management and sales positions, computer and software trading start-upcompanies, Europe, US. 1993, joined QIAGEN, when the company had just 30 employees and revenues of approximately $2 million. Former Member, German Corporate Governance Commission. Director: AdvaMedDx (US in-vitro diagnostics industry organization); ALDA (Analytical, Life Science & Diagnostics Association).
Show more...Investment focus
- Industry: Medical, Genetics, Health Care
- Stage:Seed
- Geography: United States, United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Valar Labs — AI to Make Oncologists Smarter
- Relation Therapeutics — Relation uses machine learning to develop drugs for pressing unmet need.
William Armitage is the Co-Founder & CFO ,Advisor of The Game Day.
Show more...Investment focus
- Industry: FinTech, Software, Health Care
- Stage:Seed, Angel, Pre-Seed
- Geography: United Kingdom, Chile
Investor stats
- Total investments: 5
- Lead/follow: no public data
Portfolio highlights
- Global 66 — Global 66 is an international online payment platform that allows customers to transfer money with rates up.
- Tallarium — Tallarium - The definitive pre-trade data and analytics platform for OTC energy markets, driven by data science
- Alphagreen Group — Alphagreen Group is a global acquisition and incubation platform with a health & wellness focus. We help brands to scale via our own distribution channels and an extensive external omni-channel network. Build: We build brands using our marketplace and other sources to inform us on consumer demand. We automate the sales of products acrossvarious eCommerce channels, from DTC, on Alphagreen.io, Amazon, affiliates and other channelsAcquire: We acquire high calibre profitable health and wellness brands. We use our data and network to qualify existing products to forecast future growth and automate the management of assets once acquiredScale: We scale brands using our expertise in growth hacking, existing tech infrastructure and an experienced team. Distribution includes via DTC, alphagreen.io and external marketplaces such as Amazon.
Sidar Sahin is Founder & CEO at Peak Games.
Show more...Investment focus
- Industry: Medical, mHealth, Health Care
- Stage:Series A
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Anima — Anima's online patient triage speeds up the clinical workflow 10x and allows providers to deliver the right care for patients within 24 hours.Millions of patients with serious problems are missed and die every year because there isn’t adequate information flow between medical appointments. Patients submit their problems and requests onAnimainstead of waiting for an appointment, and Anima sends an actionable report to their provider with trends, risks and recommendations.
Andrew MacKay
Show more...Investment focus
- Industry: Medical, Hospital, Health Care
- Stage:Seed
- Geography: United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- MyHealthPal — MyHealthPal is a health & wellbeing app to promote healthy living and help you manage your own or other people's health conditions.
- Materials Nexus — Accelerating change to net-zero materials
Henry is a trained doctor with extensive hospital experience who co-founded Four Eyes Insight to put his talent for finding strategic solutions and planning into helping the NHS.His interest in medical resource management developed during his junior doctor training at Bart’s and the Royal London and he helped trusts tackle the significantchallenges of rotas and the New Deal as Junior Doctors’ Advisor at the London Regional Action Team.Establishing Zircadian Ltd, a software development company focusing on a portfolio of solutions to help NHS organisations plan and organise their medical workforce more strategically and effectively in 2000, he sold it on 11 years later to Allocate with over 140 NHS clients using its products.
Show more...Investment focus
- Industry: Medical, Health Care, Health Diagnostics
- Stage:Series A
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Hexarad — Hexarad is a radiologist-led radiology company, which combines powerful tech and expert people to provide quick, accurate diagnoses. We have developed the Hexarad Platform, a unique and all-encompassing radiology solution powered by an intelligent allocative efficiency engine.
Sachin Agrawal
Show more...Investment focus
- Industry: Medical, Health Care, Health Diagnostics
- Stage:Series A
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Hexarad — Hexarad is a radiologist-led radiology company, which combines powerful tech and expert people to provide quick, accurate diagnoses. We have developed the Hexarad Platform, a unique and all-encompassing radiology solution powered by an intelligent allocative efficiency engine.
David Prior is the former chair of the UK's National Health Service.
Show more...Investment focus
- Industry: Health Care, Medical, Software
- Stage:Seed
- Geography: Belgium, United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- TORTUS AI — Innovative medical AI which revolutionises the healthcare industry by enhancing clinical operations and patient care. Book a free demo today.
- Awell Health — Ollie is a vast library of over 100 interface blocks with complete Webflow CMS integration. Build beautiful websites in less time than ever.
Johnathan Matlock is Co-Founder Science Angel Syndicate.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Seed, Pre-Seed
- Geography: United Kingdom
Investor stats
- Total investments: 10
- Lead/follow: no public data
Portfolio highlights
- OutSee — We are well-versed in a variety of genomics, AI and cohort analysis techniques. We are also bioinformatics generalists and work with just about any ...
- EnsiliTech — EnsiliTech is a biotechnology start-up developing ensilication, a platform technology, to remove the need for refrigeration when transporting and storing vaccines and biologicals
- Halo Therapeutics — Halo Therapeutics is based in England. Develops safe pan coronavirus antiviral drugs for Covid-19 that can be administered by patients.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Jim Mellon is an international investor with interests in several industries. After leaving Oxford, where he studied PPE, (Philosophy, Politics and Economics) he worked in Asia and the United States for two fund management companies, GT and Thornton, before establishing his own business in 1991. His business operations include two components, alisted fund management company called Charlemagne Capital, and an Asian mining group, Regent Pacific.In addition, Mr. Mellon is Co-Chairman of West African Minerals Corporation and Regent Pacific Group. He is on the board of a number of public quoted companies, including Brazilian Gold Corporation, Charlemagne Capital Limited, Manx Financial Group, Plethora Solutions, Polo Resources, Port Erin Biophara Investments Limited, and the Speymill plc. He is the life tenant of a trust which owns the Burnbrae Group, which has substantial assets in the biotechnology, financial services, property, mining and leisure sectors. Mr. Mellon spends most of his time working on startup ideas and investing. His book, “Wake Up!” was published in 2005; his second book "10 Investments for the Ten Years Ahead" was published in 2008. In 2012, he co-wrote "Cracking the Code" which focuses on the biotechnology sector and how to profit from it. Mr. Mellon lives in the Isle of Man, Brussels and Ibiza and is an honorary fellow of Oriel College, Oxford.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Food and Beverage
- Stage:Series A, Seed
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 28
- Lead/follow: no public data
Portfolio highlights
- Voxia — Amy collects and analyzes information from all over the web and provides actionable insights about your leads, prospects and clients, all in one click.
- Monaco Foundry — We are a team of Serial Entrepreneurs, former Senior Government Advisors and Fortune 500 Executives. A global venture accelerator that invests in early to mid-stage companies and their growth through a unique sweat equity model.
- The Duppy Share — The Duppy Share Caribbean Rum is the best rum for cocktails, mixed drinks and rum gifts. Try all our rum recipes, from rum and ginger to dark rum punch.
Brian Kennedy
Show more...Investment focus
- Industry: Music, Medical, Commercial
- Stage:Angel
- Geography: United States, United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Gigmor — Booking live music has never been this easy!
- Ryboquin — Ryboquin™ uses its expertise to turn under-developed intellectual property ideas into viable commercial realities. Founded in Scotland, Ryboquin Ltd is a privately held, virtual pharmaceutical company focused on commercialising patented technologies in the area of human cancer medicine.Founded in Scotland, Ryboquin is a privately held, virtualpharmaceutical company focused on commercializing patented technologies in the area of human cancer medicine.
Carlos Ballarati - Founding partner @ Consulta do Bem
Show more...Investment focus
- Industry: Medical, Database, Consulting
- Stage:Pre-Seed
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- OPEN Health — OPEN Health is a healthcare agency that provides market access strategy, health economic modeling and meta-analysis patient engagement, patient-centered outcomes, real-world evidence and data analytics, medical affairs consultancy and strategy, publications planning and delivery, scientific, communications, learning and development.
Yusuf Hamied is a Cambridge-educated Chemist and the Non-Executive Chairman of the Board of Directors at Cipla, a large generic pharmaceuticals company founded in 1935 by his father, Khwaja Abdul Hamied. Yusuf became a global celebrity for his role in defying Western multinational pharmaceutical companies in order to provide generic AIDS treatmentsand other drugs to treat poor people in the developing world. After completing his doctorate in 1960, Yusuf joined the family company and vowed to break the dominance of foreign multinationals over the Indian pharmaceutical market by developing cheap generic drugs. Yusuf helped persuade the Indian government to change Indian patent law in 1972, permitting medicines to be copied even if they were under international patent, as long as the process was not the same. The law transformed the Indian pharmaceutical industry, enabling his and other companies to grow by manufacturing generic drugs. In 2001 Yusuf convulsed the global healthcare industry by promising and then delivering a triple drug cocktail, Triomune, that helped fight against HIV and AIDS at prices far lower than those available internationally. Yusuf discusses his subsequent anger when, in 2005, the Indian government brought its patent laws in line with those of the developed world, prohibiting the copying of drugs patented after 1995 without a license and his resentment that he had thereafter “to go with a begging bowl to the multinationals” for licenses. This interview provides not only a personal perspective on how India’s third largest pharmaceutical firm was created, but contributes to the broad debates on the costs and benefits of intellectual property laws, particularly their impact on people who are denied life-saving drugs by their inability to pay for them. Working for Cipla as Managing Director for nearly 52 years, Yusuf was also the 28th richest Indian during one time. ‘CNN-IBN Indian of the year’ and one among the ’25 greatest global living legends’ were the titles that Yusuf won for his reign in the pharma world majorly for making medicines affordable to the poor. Yusuf was awarded with the civil honorary Padma Bhushan from then president APJ Abdul Kalam in the year 2005 for his fight against AIDS, which he often said was going to be as damaging to the society as a massive earthquake would be, if ignored. Yusuf earned his Bachelor's degree (1956), Master's degree (1957) and Ph.D. (1960) in Chemistry from University of Cambridge.
Show more...Investment focus
- Industry: Medical, Medical Device
- Stage:Seed
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- 1inhaler — 1inhaler operates as a developer of drug delivery device.
Sir Brian Souter is co-founder and Chairman of Stagecoach plc, having retired as Chief Executive in May 2013.Whilst he does not sit with the Souter Investments team in Edinburgh, Sir Brian is active in all investment decision making processes and sits on the boards of our European bus operators (PolskiBus.com and OnniBus.com) and New Zealandtransport group (InMotion).Sir Brian is currently the Vice-President of the Institute of Chartered Accountants of Scotland.
Show more...Investment focus
- Industry: Medical, Commercial, Health Care
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Ryboquin — Ryboquin™ uses its expertise to turn under-developed intellectual property ideas into viable commercial realities. Founded in Scotland, Ryboquin Ltd is a privately held, virtual pharmaceutical company focused on commercialising patented technologies in the area of human cancer medicine.Founded in Scotland, Ryboquin is a privately held, virtualpharmaceutical company focused on commercializing patented technologies in the area of human cancer medicine.
Graduate, Harvard Univ. and Harvard Business School. Chairman and Managing Director, Mahindra Group. Thought leader in Indian business. Serves on many industry confederations. Initiated the Nanhi Kali programme to provide free education to economically underprivileged girls in India. Co-Founder, Naandi Danone, India's largest safe drinkingwater provider to rural areas. Life Trustee, Board of Naandi Foundation, which provides meals to 1.3 million children daily. Co-Chair, World Economic Forum Annual Meeting 2009. Named among World’s 50 Greatest Leaders, Fortune Magazine (2014); named one of the top 25 most powerful business people in Asia, Fortune Magazine (2011).
Show more...Investment focus
- Industry: Education, Artificial Intelligence, Social Media
- Stage:Seed, Angel, Series A
- Geography: India, United States, United Kingdom
Investor stats
- Total investments: 12
- Lead/follow: no public data
Portfolio highlights
- Agnikul — Agnikul Cosmos designs and manufactures orbital-class launch vehicles powered by 3D-printed engines. From custom payloads to affordable private launches, we make space access simple, scalable, and mission-focused.
- Harvested Robotics — Harvested Robotics is an ag-tech company that focuses on safeguarding farms from weeds and diseases by lasers, robotics, and AI technology.
- Genrobotics Medical & Mobility — India's top-rated gait trainer, G Gaiter! Our AI-powered, robot assisted gait trainer accelerates neurorehabilitation for faster recovery.
Inaki Berenguer is the President and Co-founder at iPronics Programmable Photonics.
Show more...Investment focus
- Industry: Financial Services, FinTech, E-Commerce
- Stage:Seed, Angel, Pre-Seed
- Geography: Spain, United States, United Kingdom
Investor stats
- Total investments: 25
- Lead/follow: no public data
Portfolio highlights
- Ukio — Artfully designed fully furnished apartments available for extended stays
- Paack — Find the ideal delivery solution to integrate into your e-commerce. We adapt to your business, providing your customers with an amazing experience.
- Openlytics — Openlytics is a visual analytics platform. It allows Data Workers to create pipelines for data transformation and analysis, in a visual way. Our mission is to empower everyone in the organization to solve data problems, without waiting for developers.Openlytics is an early-stage company, looking to build a founding team that can shape thedirection of the product. We’re seed-funded, remote-first, and hiring.If you're interested in learning more, email us at hello@openlytics.io.
Alex Macdonald is the Co-Founder and CEO of sequel - an investment platform on a mission to help athletes build a legacy for their families and the world. He previously Co-Founded Velocity Black, raised more than $40m in funding, and which was successfully exited to US Bank Capital One in 2023. He is a serial angel investor having invested in 50early stage startups and funds.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, FinTech
- Stage:Pre-Seed, Seed, Series A
- Geography: United Kingdom, United States, France
Investor stats
- Total investments: 32
- Lead/follow: no public data
Portfolio highlights
- Kalder — Kalder is a unified web3 brand loyalty platform for brands and creators to drive meaningful engagement, onboard new users, and reward superfan communities.
- Stelia — Stelia stands at the forefront of the AI infrastructure revolution and is driving the transition from Internet 2.0, designed for data movement, to Internet 3.0, designed for data mobility, enabling the seamless flow and processing of data across diverse environments. With its ground-breaking HyperBand platform, Stelia enables businesses toharness the full potential of AI. The company's mission is to become the backbone of the next generation of data mobility, empowering organizations across industries to accelerate innovation, optimize operations, and drive transformative growth. Stelia will be at the gravitational centre of the AI infrastructure ecosystem – a trusted partner and catalyst for change that brings together forward-thinking businesses, technology leaders, and industry experts to shape the future of AI. It was founded in 2021 and is located in London, United Kingdom.
- Fundably — Fundably - Get The Right UK Business Loan | Access £1k-£2m
Charlotte Scott
Show more...Investment focus
- Industry: Medical, Health Care, Pharmaceutical
- Stage:Seed
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: no public data
Phil founded Health Intelligence in 1996 and maintains a vital role in the company shaping strategy and innovation. After graduating from Keele with an MBA on the Health Executive Programme, Phil spent thirteen years in the NHS as a senior manager responsible for I.T., registration and screening functions. This experience from within the NHS andprivate sector has given him an in-depth understanding of how cross sector population-based solutions can help the NHS overcome key challenges.
Show more...Investment focus
- Industry: Medical, Hospital, Medical Device
- Stage:Seed
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- AI-Sight — AI Sight Limited delivers next-generation AI-powered diabetic eye screening to enhance accuracy, speed, and accessibility across healthcare systems
Medical Angel investor funding in United Kingdom at a glance
Stats across 112 deals from 141 investors.
Access all 141 angel investors in United Kingdom Medical startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Angel Investors in United Kingdom investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 141 angel investors investing in United Kingdom Medical startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!